Avaliação Dos Genes De Herpesvírus Bovino Tipo 5 No Controle Da Apoptose

Total Page:16

File Type:pdf, Size:1020Kb

Avaliação Dos Genes De Herpesvírus Bovino Tipo 5 No Controle Da Apoptose UNIVERSIDADE DE BRASÍLIA FACULDADE DE AGRONOMIA E MEDICINA VETERINÁRIA PROGRAMA DE PÓS-GRADUAÇÃO EM SAÚDE ANIMAL AVALIAÇÃO DOS GENES DE HERPESVÍRUS BOVINO TIPO 5 NO CONTROLE DA APOPTOSE ALICE MARTINS DA SILVA DISSERTAÇÃO DE MESTRADO EM SAÚDE ANIMAL BRASÍLIA-DF JULHO/2019 UNIVERSIDADE DE BRASÍLIA FACULDADE DE AGRONOMIA E MEDICINA VETERINÁRIA PROGRAMA DE PÓS-GRADUAÇÃO EM SAÚDE ANIMAL AVALIAÇÃO DOS GENES DE HERPESVÍRUS BOVINO TIPO 5 NO CONTROLE DA APOPTOSE ALICE MARTINS DA SILVA ORIENTADOR: JOSÉ RENATO JUNQUEIRA BORGES DISSERTAÇÃO DE MESTRADO EM SAÚDE ANIMAL PUBLICAÇÃO 165/2019 BRASÍLIA/DF JULHO/2019 UNIVERSIDADE DE BRASÍLIA FACULDADE DE AGRONOMIA E MEDICINA VETERINÁRIA PROGRAMA DE PÓS-GRADUAÇÃO EM SAÚDE ANIMAL AVALIAÇÃO DOS GENES DE HERPESVÍRUS BOVINO TIPO 5 NO CONTROLE DA APOPTOSE Alice Martins da Silva DISSERTAÇÃO DE MESTRADO SUBMETIDA AO PROGRAMA DE SAÚDE ANIMAL COMO PARTE DOS REQUISITOS À OBTENÇÃO DO GRAU DE MESTRE EM SAÚDE ANIMAL. BRASÍLIA, DF, 10 DE JULHO DE 2019. REFERÊNCIA BIBLIOGRÁFICA E CATALOGAÇÃO Silva.A.M. Avaliação dos genes de herpesvírus bovino tipo 5 no controle da apoptose. Faculdade de Agronomia e Medicina Veterinária, Universidade de Brasília. UnB. 2019. 65p. Dissertação de mestrado. Documento formal autorizando reprodução desta dissertação de mestrado para empréstimo ou comercialização exclusivamente para fins acadêmicos. Foi passado pelo autor à Universidade de Brasília e acha-se arquivado na Secretaria do Programa. O autor reserva para si os outros direitos autorais de publicação. Nenhuma parte desta dissertação de mestrado pode ser reproduzida sem a autorização por escrito do autor. Citações são estimuladas desde que citada a fonte. FICHA CATALOGRÁFICA Silva, Alice Martins. Avaliação dos genes de herpesvírus bovino tipo 5 no controle da apoptose. Alice Martins da Silva; orientação de José Renato Junqueira Borges - Brasília, 2019. 65 p: il. Dissertação de Mestrado (M) – Universidade de Brasília/ Faculdade de Agronomia e Medicina Veterinária, 2019. 1. Alfaherpesvírus bovino tipo 5. 2. US3. 3. Apoptose I. Borges, J.R.J. II. Avaliação dos genes de herpesvírus bovino tipo 5 no controle da apoptose. O presente trabalho foi realizado com apoio da Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Código de Financiamento 001. iv DEDICATÓRIA À Ariane Abrunhosa e Luiz Martins da Silva. Meus companheiros de travessias. v AGRADECIMENTOS Ao Professor Dr. José Renato Junqueira por acreditar em mim e me proporcionar a liberdade de realizar o mestrado na área de Microbiologia. Agradeço às professoras Dra. Lígia Cantarino e Dra. Simone Perecmanis por terem me incentivado a realizar o mestrado e me ajudado a crescer desde a graduação. Ambas são para mim, uma referência de profissionalismo e dedicação. Ao Professor Dr. Bergmann Ribeiro pela paciência, cordialidade, ensinamentos e, principalmente, pelo exemplo de mestre e pesquisador. Agradeço pelas sábias palavras, quando tudo parecia não dar certo. Sem o seu apoio nada disso teria sido possível. Um agradecimento especial ao Professor Dr. Fabrício Souza Campos, pelo acompanhamento no desenvolvimento desse trabalho, pelas correções e pela paciência e confiança depositadas em mim. À Professora Dra. Ana Cláudia Franco, a Prof. Dra. Ângela Patrícia Santana e ao Prof. Dr. Renato Resende por aceitarem participar da banca. Agradeço a todos os técnicos e terceirizados do Hospital Veterinário de Pequenos Animais da UnB: Maurício Macêdo, Cléia Nunes, Ernane Paiva, Marcela Scalon, Bruno Dallago, Salvina, Célia, Dino, Léo e a toda equipe do Laboratório de Microbiologia Veterinária pela amizade, boa companhia e pelo café da tarde de todos esses anos. Aos doutores Leonardo Assis e Fabrício Morgado pessoas que me aconselharam, gastaram longas horas me explicando técnicas, refazendo experimentos, revisando e discutindo resultados. Ainda, agradeço a convivência e bons momentos com todos os colegas do Laboratório de Baculovírus e Laboratório de Virologia Vegetal: estagiários, mestrandos, pós- doutorandos, que de alguma maneira me ajudaram a amadurecer tanto profissionalmente como pessoalmente. Às amigas de uma vida, Luciana Santos, Sabrina Azevedo, Nanci Hokino, Letícia Muller que independente do momento ou da distância, sempre estiveram por perto. Agradeço ao meu namorado Juliano Terra que suportou a distância nesses anos e que esteve comigo em todos os momentos, me apoiando e encorajando a ser sempre melhor. A toda minha família, mas principalmente à minha incrível mãe, Ariane Abrunhosa, que me apoiou e nunca mediu esforços para que eu realizasse meus sonhos. Ao meu pai, Luiz Martins da Silva, meu primeiro professor, por ser tão amoroso e um exemplo de pessoa em tantos aspectos. Aos órgãos de fomento, FAPDF e CAPES que financiaram esse projeto. À Universidade de Brasília, essa incrível instituição, e a todos os seus funcionários e professores, muito obrigada! vi SUMÁRIO Página RESUMO VIII ABSTRACT IX LISTA DE ABREVIATURAS E SÍMBOLOS X 1. INTRODUÇÃO 1 2. OBJETIVOS 3 3. REVISÃO BIBLIOGRÁFICA 4 3.1. Alfaherpesvírus bovino tipo 5 4 3.2. Epidemiologia e controle 5 3.3. Etiologia – descrição do agente 6 3.4. Genoma 7 3.4.1. Ciclo Replicativo 8 3.4.2. Adsorção, fusão e penetração 9 3.4.3. Transporte e penetração nuclear 9 3.4.4. Expressão gênica e replicação do genoma 9 3.4.5. Morfogênese, maturação e egresso 10 3.4.6. Latência 11 3.4.7. Gene US3 13 3.5. Apoptose 15 3.6. Baculovírus: características gerais 17 3.6.1. Baculovírus no controle da morte celular programada 19 4. REFERÊNCIAS 22 5. INFORMAÇÕES ADICIONAIS 29 6. ARTIGO CIENTÍFICO 30 vii RESUMO AVALIAÇÃO DOS GENES DE HERPESVÍRUS BOVINO TIPO 5 NO CONTROLE DA APOPTOSE O Alphaherpesvirus bovino tipo 5 (BoHV-5) é um dos principais agentes responsáveis pela meningoencefalite em bovinos no Brasil, causando perdas econômicas significativas. Sabe-se que outros vírus da família Herpesviridae, como o Alphaherpesvirus bovino tipo 1, o Alphaherpesvirus suíno tipo 1 e o Alphaherpesvirus humano tipo 1 e 2, codificam genes homólogos ao BoHV-5, com reconhecida ação no controle da apoptose. O objetivo deste trabalho foi expressar o gene BoHV-5 US3 em um sistema de expressão baseado em baculovírus para a produção da proteína serina/treonina quinase e avaliar sua atividade no controle da apoptose in vitro. Um baculovírus recombinante derivado do Autographa californica multiple nucleopolyhedrovirus (AcMNPV) contendo o gene US3 e uma deleção no gene p35 anti-apoptótico de baculovírus foi construído usando o sistema Bac-to-BacTM. Este baculovírus recombinante foi utilizado para avaliar a atividade anti-apoptótica do gene US3 em células de inseto comparando-o com outros dois recombinantes de AcMNPV. Um vírus contendo uma cópia funcional do gene anti-apoptótico p35 de AcMNPV e outro AcMNPV p35 knockout com o gene iap-3 anti-apoptótico do vírus Anticarsia gemmatalis multiple nucleopolyhedrovirus (AgMNPV). Descobrimos que o nível de caspase (indicador de apoptose) foi maior nas células de inseto infectadas com o vírus recombinante contendo o gene US3 do que nas células infectadas com os recombinantes AcMNPV com os genes p35 e iap-3. Além disso, o gene iap-3 AgMNPV foi capaz de substituir eficientemente o gene p35 no controle da apoptose durante a infecção de células de insetos pelo recombinante AcMNPV contendo o gene iap-3. Estes resultados indicam que o gene da proteína quinase BoHV-5 US3 não é capaz de bloquear a apoptose em células de inseto induzidas pela infecção de um AcMNPV p35 knockout. Palavras-chave: Alfaherpesvírus bovino tipo 5, US3, apoptose. viii ABSTRACT EVALUATION OF BOVINE TYPE 5 HERPESVIRUS GENES IN THE CONTROL OF APOPTOSIS Bovine alphaherpesvirus type 5 (BoHV-5) is one of the main agents responsible for meningoencephalitis in bovines in Brazil, causing significant economic losses. It is known that other viruses of the Herpesviridae family such as Bovine alphaherpesvirus type 1, Swine alphaherpesvirus type 1 and the Human alphaherpesvirus types 1 and 2 encode genes homologous to BoHV-5, with recognized action in the control of apoptosis. The objective of this work was to express the BoHV-5 US3 gene in a baculovirus based expression system for the production of the serine/threonine kinase protein and to evaluate its activity in the control of apoptosis in vitro. A recombinant baculovirus derived from the Autographa californica multiple nucleopolyhedrovirus (AcMNPV) containing the US3 gene and a deletion in the baculovirus anti-apoptotic gene p35 gene was constructed using the Bac-to-BacTM system. This recombinant baculovirus was used to evaluate the anti-apoptotic activity of the US3 gene in insect cells comparing with two other AcMNPV recombinants. One containing a functional copy of the AcMNPV anti-apoptotic p35 gene and an AcMNPV p35 knockout virus with the anti-apoptotic iap-3 gene from Anticarsia gemmatalis multiple nucleopolyhedrovirus (AgMNPV). We found that the caspase level (indicator of apoptosis) was higher in insect cells infected with the US3-contanining recombinant virus than in cells infected with the AcMNPV recombinants containing the p35 and iap-3 genes. Moreover, the AgMNPV iap-3 gene was able to efficiently substitute the p35 gene in the control of apoptosis during infection of insect cells by the AcMNPV recombinant containing the iap-3 gene. These results indicate that the BoHV-5 US3 protein kinase gene is not able to block apoptosis in insect cells induced by the infection of a p35 knockout AcMNPV. Key words: Alphaherpesvirus Bovine 5, US3, apoptosis. ix LISTA DE ABREVIATURAS E SÍMBOLOS AcMNPV:
Recommended publications
  • (12) United States Patent (10) Patent No.: US 8,993,581 B2 Perrine Et Al
    US00899.3581B2 (12) United States Patent (10) Patent No.: US 8,993,581 B2 Perrine et al. (45) Date of Patent: Mar. 31, 2015 (54) METHODS FOR TREATINGVIRAL (58) Field of Classification Search DSORDERS CPC ... A61K 31/00; A61K 31/166; A61K 31/185: A61K 31/233; A61K 31/522: A61K 38/12: (71) Applicant: Trustees of Boston University, Boston, A61K 38/15: A61K 45/06 MA (US) USPC ........... 514/263.38, 21.1, 557, 565, 575, 617; 424/2011 (72) Inventors: Susan Perrine, Weston, MA (US); Douglas Faller, Weston, MA (US) See application file for complete search history. (73) Assignee: Trustees of Boston University, Boston, (56) References Cited MA (US) U.S. PATENT DOCUMENTS (*) Notice: Subject to any disclaimer, the term of this 3,471,513 A 10, 1969 Chinn et al. patent is extended or adjusted under 35 3,904,612 A 9/1975 Nagasawa et al. U.S.C. 154(b) by 0 days. (Continued) (21) Appl. No.: 13/915,092 FOREIGN PATENT DOCUMENTS (22) Filed: Jun. 11, 2013 CA 1209037 A 8, 1986 CA 2303268 A1 4f1995 (65) Prior Publication Data (Continued) US 2014/OO45774 A1 Feb. 13, 2014 OTHER PUBLICATIONS Related U.S. Application Data (63) Continuation of application No. 12/890,042, filed on PCT/US 10/59584 Search Report and Written Opinion mailed Feb. Sep. 24, 2010, now abandoned. 11, 2011. (Continued) (60) Provisional application No. 61/245,529, filed on Sep. 24, 2009, provisional application No. 61/295,663, filed on Jan. 15, 2010. Primary Examiner — Savitha Rao (74) Attorney, Agent, or Firm — Nixon Peabody LLP (51) Int.
    [Show full text]
  • (Epstein- Barr Virus) No Líquido Cefalorraquidiano De Crianças Com Suspeita De Meningoencefalite No Estado De Minas
    1 Universidade Federal de Minas Gerais Programa de Pós-Graduação em Microbiologia Detecção de human gammaherpesvirus 4 (Epstein- Barr virus) no líquido cefalorraquidiano de crianças com suspeita de meningoencefalite no estado de Minas Gerais Belo Horizonte 2020 2 NATHALIA MARTINS QUINTÃO Detecção de human gammaherpesvirus 4 (Epstein- Barr virus - EBV) no líquido cefalorraquidiano de crianças com suspeita de meningoencefalite no estado de Minas Gerais Dissertação de mestrado apresentada ao Programa de Pós-Graduação em Microbiologia do Instituto de Ciências Biológicas da Universidade Federal de Minas Gerais, como requisito à obtenção do título de Mestre em Microbiologia. Orientadora: Prof.ª. Dr.ª Erna Gessien Kroon Belo Horizonte 2020 3 4 5 RESUMO Epstein-Barr virus pertence à subfamília Gammaherpesvirinae da família Herpesviridae e é o agente etiológico da mononucleose infecciosa. A transmissão de EBV geralmente é pela saliva, sendo o quadro clássico de infecção primária a mononucleose apenas 5% dos casos evoluem para quadros de meningoencefalites. Os grupos de risco são principalmente crianças na primeira infância e pacientes imunocomprometidos. No Brasil, nos últimos 10 anos foram registrados aproximadamente 22 mil casos de meningites e encefalites virais, sendo 52% dos casos em crianças com até 14 anos de idade. O ensaio de PCR em tempo real (qPCR) revoluciona o diagnóstico de neuroinfecções virais. O objetivo deste trabalho foi detectar a presença de DNA genômico e de mRNA de EBV por qPCR para casos de meningoencefalites em pacientes de Minas Gerais e construir, com base na análise de prontuário dos pacientes e dados disponíveis no DATASUS, um breve panorama dos casos de meningoencefalites por EBV.
    [Show full text]
  • Expression, Delivery and Function of Insecticidal Proteins Expressed by Recombinant Baculoviruses
    Viruses 2015, 7, 422-455; doi:10.3390/v7010422 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Expression, Delivery and Function of Insecticidal Proteins Expressed by Recombinant Baculoviruses Jeremy A. Kroemer 1,2, Bryony C. Bonning 1 and Robert L. Harrison 3,* 1 Department of Entomology, Iowa State University, Ames, IA 50011, USA; E-Mails: [email protected] (J.A.K.); [email protected] (B.C.B.) 2 Current location and contact information: Monsanto Company, 700 Chesterfield Parkway West, Chesterfield, MO 63017, USA 3 USDA-ARS Beltsville Agricultural Research Center, Invasive Insect Biocontrol & Behavior Laboratory, 10300 Baltimore Ave, Beltsville, MD 20705, USA * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-301-504-5249; Fax: +1-301-504-5104. Academic Editor: John Burand and Madoka Nakai Received: 25 November 2014 / Accepted: 15 January 2015 / Published: 21 January 2015 Abstract: Since the development of methods for inserting and expressing genes in baculoviruses, a line of research has focused on developing recombinant baculoviruses that express insecticidal peptides and proteins. These recombinant viruses have been engineered with the goal of improving their pesticidal potential by shortening the time required for infection to kill or incapacitate insect pests and reducing the quantity of crop damage as a consequence. A wide variety of neurotoxic peptides, proteins that regulate insect physiology, degradative enzymes, and other potentially insecticidal proteins have been evaluated for their capacity to reduce the survival time of baculovirus-infected lepidopteran host larvae. Researchers have investigated the factors involved in the efficient expression and delivery of baculovirus-encoded insecticidal peptides and proteins, with much effort dedicated to identifying ideal promoters for driving transcription and signal peptides that mediate secretion of the expressed target protein.
    [Show full text]
  • Diversity of Large DNA Viruses of Invertebrates ⇑ Trevor Williams A, Max Bergoin B, Monique M
    Journal of Invertebrate Pathology 147 (2017) 4–22 Contents lists available at ScienceDirect Journal of Invertebrate Pathology journal homepage: www.elsevier.com/locate/jip Diversity of large DNA viruses of invertebrates ⇑ Trevor Williams a, Max Bergoin b, Monique M. van Oers c, a Instituto de Ecología AC, Xalapa, Veracruz 91070, Mexico b Laboratoire de Pathologie Comparée, Faculté des Sciences, Université Montpellier, Place Eugène Bataillon, 34095 Montpellier, France c Laboratory of Virology, Wageningen University, Droevendaalsesteeg 1, 6708 PB Wageningen, The Netherlands article info abstract Article history: In this review we provide an overview of the diversity of large DNA viruses known to be pathogenic for Received 22 June 2016 invertebrates. We present their taxonomical classification and describe the evolutionary relationships Revised 3 August 2016 among various groups of invertebrate-infecting viruses. We also indicate the relationships of the Accepted 4 August 2016 invertebrate viruses to viruses infecting mammals or other vertebrates. The shared characteristics of Available online 31 August 2016 the viruses within the various families are described, including the structure of the virus particle, genome properties, and gene expression strategies. Finally, we explain the transmission and mode of infection of Keywords: the most important viruses in these families and indicate, which orders of invertebrates are susceptible to Entomopoxvirus these pathogens. Iridovirus Ó Ascovirus 2016 Elsevier Inc. All rights reserved. Nudivirus Hytrosavirus Filamentous viruses of hymenopterans Mollusk-infecting herpesviruses 1. Introduction in the cytoplasm. This group comprises viruses in the families Poxviridae (subfamily Entomopoxvirinae) and Iridoviridae. The Invertebrate DNA viruses span several virus families, some of viruses in the family Ascoviridae are also discussed as part of which also include members that infect vertebrates, whereas other this group as their replication starts in the nucleus, which families are restricted to invertebrates.
    [Show full text]
  • (Title of the Thesis)*
    INVESTIGATING THE ROLES OF HERPES SIMPLEX VIRUS TYPE 2 PROTEINS UL21 AND US3 IN REGULATION OF THE NUCLEAR EGRESS COMPLEX by Jamil H. Muradov A thesis submitted to the Graduate Program in Microbiology and Immunology in the Department of Biomedical and Molecular Sciences In conformity with the requirements for the degree of Master of Sciences Queen’s University Kingston, Ontario, Canada (May, 2021) Copyright © Jamil H. Muradov, 2021 Abstract Herpes Simplex Virus 2 (HSV-2) nuclear egress is mediated by viral nuclear egress complex (NEC) proteins, pUL31 and pUL34, found at the inner nuclear membrane of infected cells (INM). Nuclear egress requires successful primary envelopment of a capsid at the INM, budding of the resulting capsid-containing vesicle into the perinuclear space (PNS), de-envelopment of the perinuclear virion at the outer nuclear membrane and release of the capsid into the cytoplasm. In this work, we demonstrate that HSV-2 pUL31 and pUL34 are phosphorylated by a viral protein kinase, called pUs3, which serves to prevent excessive INM deformation and accumulation of the primary enveloped virions (PEVs) in PNS after successful primary envelopment of capsids. It was found that a tegument protein, pUL21, modulates pUs3 dependent pUL31 and pUL34 phosphorylation. We also determined that in UL21-knockout infected cells, pUs3 is differentially modified, and this modification is likely an autophosphorylation. Higher levels of pUs3 phosphorylation were shown to result in augmentation of pUs3/PKA substrate phosphorylation levels, including pUL31 and pUL34. Excessive phosphorylation of the NEC components caused their aberrant distribution at the INM, extravagation of the nuclear envelope and failure of the capsids to undergo primary envelopment at the INM.
    [Show full text]
  • Repurposing the Human Immunodeficiency Virus (Hiv) Integrase
    REPURPOSING THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) INTEGRASE INHIBITOR RALTEGRAVIR FOR THE TREATMENT OF FELID ALPHAHERPESVIRUS 1 (FHV-1) OCULAR INFECTION A Dissertation Presented to the Faculty of the Graduate School of Cornell University In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy by Matthew Robert Pennington August 2018 © 2018 Matthew Robert Pennington REPURPOSING THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) INTEGRASE INHIBITOR RALTEGRAVIR FOR THE TREATMENT OF FELID ALPHAHERPESVIRUS 1 (FHV-1) OCULAR INFECTION Matthew Robert Pennington, Ph.D. Cornell University 2018 Herpesviruses infect many species, inducing a wide range of diseases. Herpesvirus- induced ocular disease, which may lead to blindness, commonly occurs in humans, dogs, and cats, and is caused by human alphaherpesvirus 1 (HHV-1), canid alphaherpesvirus (CHV-1), and felid alphaherpesvirus 1 (FHV-1), respectively. Rapid and effective antiviral therapy is of the utmost importance to control infection in order to preserve the vision of infected people or animals. However, current treatment options are suboptimal, in large part due to the difficulty and cost of de novo drug development and the lack of effective models to bridge work in in vitro cell cultures and in vivo. Repurposing currently approved drugs for viral infections is one strategy to more rapidly identify new therapeutics. Furthermore, studying ocular herpesviruses in cats is of particular importance, as this condition is a frequent disease manifestation in these animals and FHV-1 infection of the cat is increasingly being recognized as a valuable natural- host model of herpesvirus-induced ocular infection First, the current models to study ocular herpesvirus infections were reviewed.
    [Show full text]
  • Evidence to Support Safe Return to Clinical Practice by Oral Health Professionals in Canada During the COVID-19 Pandemic: a Repo
    Evidence to support safe return to clinical practice by oral health professionals in Canada during the COVID-19 pandemic: A report prepared for the Office of the Chief Dental Officer of Canada. November 2020 update This evidence synthesis was prepared for the Office of the Chief Dental Officer, based on a comprehensive review under contract by the following: Paul Allison, Faculty of Dentistry, McGill University Raphael Freitas de Souza, Faculty of Dentistry, McGill University Lilian Aboud, Faculty of Dentistry, McGill University Martin Morris, Library, McGill University November 30th, 2020 1 Contents Page Introduction 3 Project goal and specific objectives 3 Methods used to identify and include relevant literature 4 Report structure 5 Summary of update report 5 Report results a) Which patients are at greater risk of the consequences of COVID-19 and so 7 consideration should be given to delaying elective in-person oral health care? b) What are the signs and symptoms of COVID-19 that oral health professionals 9 should screen for prior to providing in-person health care? c) What evidence exists to support patient scheduling, waiting and other non- treatment management measures for in-person oral health care? 10 d) What evidence exists to support the use of various forms of personal protective equipment (PPE) while providing in-person oral health care? 13 e) What evidence exists to support the decontamination and re-use of PPE? 15 f) What evidence exists concerning the provision of aerosol-generating 16 procedures (AGP) as part of in-person
    [Show full text]
  • Hampering Herpesviruses HHV-1 and HHV-2 Infection by Extract of Ginkgo Biloba (Egb) and Its Phytochemical Constituents
    fmicb-10-02367 October 12, 2019 Time: 11:50 # 1 ORIGINAL RESEARCH published: 15 October 2019 doi: 10.3389/fmicb.2019.02367 Hampering Herpesviruses HHV-1 and HHV-2 Infection by Extract of Ginkgo biloba (EGb) and Its Phytochemical Constituents Marta Sochocka1*, Maciej Sobczynski´ 2, Michał Ochnik1, Katarzyna Zwolinska´ 1 and Jerzy Leszek3 1 Laboratory of Virology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland, 2 Department of Genomics, Faculty of Biotechnology, University of Wrocław, Wrocław, Poland, 3 Department of Psychiatry, Wrocław Medical University, Wrocław, Poland Despite the availability of several anti-herpesviral agents, it should be emphasized that the need for new inhibitors is highly encouraged due to the increasing resistant viral strains as well as complications linked with periods of recurring viral replication and reactivation of latent herpes infection. Extract of Ginkgo biloba (EGb) is a common phytotherapeutics around the world with health benefits. Limited studies, however, have addressed the potential antiviral activities of EGb, including herpesviruses such as Human alphaherpesvirus 1 (HHV-1) and Human alphaherpesvirus 2 (HHV-2). We Edited by: Anthony Nicola, evaluated the antiviral activity of EGb and its phytochemical constituents: flavonoids Washington State University, and terpenes against HHV-1 and HHV-2. Pretreatment of the herpesviruses with EGb United States prior to infection of cells produced a remarkable anti-HHV-1 and anti-HHV-2 activity. Reviewed by: The extract affected the viruses before adsorption to cell surface at non-cytotoxic Konstantin Kousoulas, Louisiana State University, concentrations. In this work, through a comprehensive anti-HHV-1 and anti-HHV-2 United States activity study, it was revealed that flavonoids, especially isorhamnetin, are responsible Oren Kobiler, Tel Aviv University, Israel for the antiviral activity of EGb.
    [Show full text]
  • Commission Directive (Eu)
    L 279/54 EN Offi cial Jour nal of the European Union 31.10.2019 COMMISSION DIRECTIVE (EU) 2019/1833 of 24 October 2019 amending Annexes I, III, V and VI to Directive 2000/54/EC of the European Parliament and of the Council as regards purely technical adjustments THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (1), and in particular Article 19 thereof, Whereas: (1) Principle 10 of the European Pillar of Social Rights (2), proclaimed at Gothenburg on 17 November 2017, provides that every worker has the right to a healthy, safe and well-adapted working environment. The workers’ right to a high level of protection of their health and safety at work and to a working environment that is adapted to their professional needs and that enables them to prolong their participation in the labour market includes protection from exposure to biological agents at work. (2) The implementation of the directives related to the health and safety of workers at work, including Directive 2000/54/EC, was the subject of an ex-post evaluation, referred to as a REFIT evaluation. The evaluation looked at the directives’ relevance, at research and at new scientific knowledge in the various fields concerned. The REFIT evaluation, referred to in the Commission Staff Working Document (3), concludes, among other things, that the classified list of biological agents in Annex III to Directive 2000/54/EC needs to be amended in light of scientific and technical progress and that consistency with other relevant directives should be enhanced.
    [Show full text]
  • The Genome and Occlusion Bodies of Marine Penaeus Monodon Nudivirus
    Yang et al. BMC Genomics 2014, 15:628 http://www.biomedcentral.com/1471-2164/15/628 RESEARCH ARTICLE Open Access The genome and occlusion bodies of marine Penaeus monodon nudivirus (PmNV, also known as MBV and PemoNPV) suggest that it should be assigned to a new nudivirus genus that is distinct from the terrestrial nudiviruses Yi-Ting Yang1,2, Der-Yen Lee3, Yongjie Wang4,5,Jer-MingHu6,Wen-HsiungLi7,8, Jiann-Horng Leu9,10, Geen-Dong Chang11,Huei-MienKe7,12, Shin-Ting Kang1,2,Shih-ShunLin13, Guang-Hsiung Kou2* andChu-FangLo1,2,14* Abstract Background: Penaeus monodon nudivirus (PmNV) is the causative agent of spherical baculovirosis in shrimp (Penaeus monodon). This disease causes significant mortalities at the larval stage and early postlarval (PL) stage and may suppress growth and reduce survival and production in aquaculture. The nomenclature and classification status of PmNV has been changed several times due to morphological observation and phylogenetic analysis of its partial genome sequence. In this study, we therefore completed the genome sequence and constructed phylogenetic trees to clarify PmNV’s taxonomic position. To better understand the characteristics of the occlusion bodies formed by this marine occluded virus, we also compared the chemical properties of the polyhedrin produced by PmNV and the baculovirus AcMNPV (Autographa californica nucleopolyhedrovirus). Results: We used next generation sequencing and traditional PCR methods to obtain the complete PmNV genome sequence of 119,638 bp encoding 115 putative ORFs. Phylogenetic tree analysis showed that several PmNV genes and sequences clustered with the non-occluded nudiviruses and not with the baculoviruses. We also investigated the characteristics of PmNV polyhedrin, which is a functionally important protein and the major component of the viral OBs (occlusion bodies).
    [Show full text]
  • B Directive 2000/54/Ec of the European
    02000L0054 — EN — 24.06.2020 — 002.001 — 1 This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document ►B DIRECTIVE 2000/54/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (seventh individual directive within the meaning of Article 16(1) of Directive 89/391/EEC) (OJ L 262, 17.10.2000, p. 21) Amended by: Official Journal No page date ►M1 Commission Directive (EU) 2019/1833 of 24 October 2019 L 279 54 31.10.2019 ►M2 Commission Directive (EU) 2020/739 of 3 June 2020 L 175 11 4.6.2020 02000L0054 — EN — 24.06.2020 — 002.001 — 2 ▼B DIRECTIVE 2000/54/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (seventh individual directive within the meaning of Article 16(1) of Directive 89/391/EEC) CHAPTER I GENERAL PROVISIONS Article 1 Objective 1. This Directive has as its aim the protection of workers against risks to their health and safety, including the prevention of such risks, arising or likely to arise from exposure to biological agents at work.
    [Show full text]
  • Genomes of Anguillid Herpesvirus 1 Strains Reveal Evolutionary Disparities and Low Genetic Diversity in the Genus Cyprinivirus
    microorganisms Article Genomes of Anguillid Herpesvirus 1 Strains Reveal Evolutionary Disparities and Low Genetic Diversity in the Genus Cyprinivirus Owen Donohoe 1,2,†, Haiyan Zhang 1,†, Natacha Delrez 1,† , Yuan Gao 1, Nicolás M. Suárez 3, Andrew J. Davison 3 and Alain Vanderplasschen 1,* 1 Immunology-Vaccinology, Department of Infectious and Parasitic Diseases, Fundamental and Applied Research for Animals & Health (FARAH), Faculty of Veterinary Medicine, University of Liège, B-4000 Liège, Belgium; [email protected] (O.D.); [email protected] (H.Z.); [email protected] (N.D.); [email protected] (Y.G.) 2 Bioscience Research Institute, Athlone Institute of Technology, Athlone, Co. N37 HD68 Westmeath, Ireland 3 MRC-Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK; [email protected] (N.M.S.); [email protected] (A.J.D.) * Correspondence: [email protected]; Tel.: +32-4-366-42-64; Fax: +32-4-366-42-61 † These first authors contributed equally. Abstract: Anguillid herpesvirus 1 (AngHV-1) is a pathogen of eels and a member of the genus Cyprinivirus in the family Alloherpesviridae. We have compared the biological and genomic fea- tures of different AngHV-1 strains, focusing on their growth kinetics in vitro and genetic content, diversity, and recombination. Comparisons based on three core genes conserved among alloher- Citation: Donohoe, O.; Zhang, H.; pesviruses revealed that AngHV-1 exhibits a slower rate of change and less positive selection than Delrez, N.; Gao, Y.; Suárez, N.M.; other cypriniviruses. We propose that this may be linked to major differences in host species and Davison, A.J.; Vanderplasschen, A.
    [Show full text]